| 2022/01/26 MfPH Workshop on Endemic COVID-19: Mathematical Insights Event1 #701031 Discussions on modeling challenges of the following public health issues: (1) What is a “definition” of post-COVID-19 new normal or the endemic state; (2) What are the necessary public-health measures (monitoring, surveillance, contact tracing, face masks, vaccine passport etc) and pharmaceutical interventions to achieve the transition from epidemic to endemic state; (3) What are the indicators that can be used for a sustained normal or “tolerable” endemic state? |
Model studies of these issues require the most current scientific evidence and the best modeling practices on, but not limited to, the following scientific and social issues: - COVID-19 vaccine and immunity (vaccine efficacy, waning of immunity, effects of booster shots, effects of vaccination of young children on the population-wide transmission, new vaccines in the pipeline, etc.);
- Mechanism, effects, and efficacy of newly available drugs for COVID-19 (e.g. Pfizer’s Paxlovid pill, approved in the UK, and Merck’s Molnupiravir pill, and others in the pipeline, monoclonal antibody treatments); impact of treatments on vaccination uptake, potential drug resistance.
- Improved understanding of human behaviours during a pandemic and how to incorporate human behaviours into models.
|